![]() (R)-(-)-Ibuprofen structure
|
Common Name | (R)-(-)-Ibuprofen | ||
---|---|---|---|---|
CAS Number | 51146-57-7 | Molecular Weight | 206.281 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 319.6±11.0 °C at 760 mmHg | |
Molecular Formula | C13H18O2 | Melting Point | 41-42ºC | |
MSDS | N/A | Flash Point | 216.7±14.4 °C |
Use of (R)-(-)-Ibuprofen(R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects. |
Name | levibuprofen |
---|---|
Synonym | More Synonyms |
Description | (R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects. |
---|---|
Related Catalog | |
Target |
NF-κB |
In Vitro | (R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, with no inhibitory effect on COX, but is involved in pathways of lipid metabolism and is incorporated into triglycerides along with endogenous fatty acids[1]. (R)-(-)-Ibuprofen (1 μM) significantly reduces NF-κB activation and completely prevents NF-κB induction at 10 μM. (R)-(-)-Ibuprofen inhibits NF-κB luciferase activity with an IC50 of 121.8 μM, weaker than that of S(+)-ibuprofen (IC50, 61.7 μM). Furthermore, (R)-(-)-Ibuprofen (10 mM) has no effect on HSF[2]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 319.6±11.0 °C at 760 mmHg |
Melting Point | 41-42ºC |
Molecular Formula | C13H18O2 |
Molecular Weight | 206.281 |
Flash Point | 216.7±14.4 °C |
Exact Mass | 206.130676 |
PSA | 37.30000 |
LogP | 3.72 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.519 |
HS Code | 2916399090 |
---|
Precursor 9 | |
---|---|
DownStream 1 | |
HS Code | 2916399090 |
---|---|
Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Inoven |
Lebrufen |
(RS)-ibuprofen |
Ibumetin |
Femadon |
2-(4-Isobutylphenyl)propionic acid |
QVY1&R D1Y1&1 |
l-Ibuprofen |
Para-Isobutylhydratropic Acid |
Ibuprofen |
(2R)-2-(4-Isobutylphenyl)propanoic acid |
(R)-2-(4-Isobutylphenyl)propanoic acid |
Benzeneacetic acid, α-methyl-4-(2-methylpropyl)- |
(±)-ibuprofen |
Novogent N |
Ibutid |
fenbid |
2-(4-Isobutylphenyl)propanoic acid |
MOTRIN |
Dolgirid |
(R)-Ibuprofen |
Amibufen |
(-)-ibuprofen |
Nurofen |
(R)-(-)-Ibuprofen |
Racemic ibuprofen |
(2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid |
Advil |
Brufen |
Dolo-Dolgit |
Seclodin |
UNII:WK2XYI10QM |
Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, (αR)- |
IbU |
Panafen |